Hangzhou Tigermed Consulting Co., Ltd
HNGZY
$3.96
-$0.1386-3.38%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 46.37M | 56.36M | 133.24M | 156.28M | 237.69M |
| Total Depreciation and Amortization | 44.80M | 44.80M | 42.08M | 44.24M | 43.02M |
| Total Amortization of Deferred Charges | 5.51M | 5.51M | 4.59M | 5.24M | 4.69M |
| Total Other Non-Cash Items | 90.44M | 73.32M | 81.32M | 48.07M | 9.71M |
| Change in Net Operating Assets | -27.22M | -27.22M | -114.31M | -121.91M | -118.31M |
| Cash from Operations | 159.91M | 152.78M | 146.91M | 131.92M | 176.80M |
| Capital Expenditure | -40.64M | -49.56M | -52.61M | -49.75M | -47.69M |
| Sale of Property, Plant, and Equipment | 296.00K | 324.90K | 97.90K | 94.40K | 788.60K |
| Cash Acquisitions | -50.74M | -50.43M | -3.92M | -48.77M | -48.48M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -638.11M | -555.75M | -727.71M | -653.92M | -58.25M |
| Cash from Investing | -729.20M | -655.43M | -784.15M | -752.35M | -153.63M |
| Total Debt Issued | 3.56B | 3.38B | 3.24B | 3.26B | 3.11B |
| Total Debt Repaid | -4.27B | -4.03B | -2.86B | -2.52B | -2.58B |
| Issuance of Common Stock | 452.28M | 410.98M | 489.29M | 442.84M | 409.64M |
| Repurchase of Common Stock | -548.75M | -548.75M | -307.71M | -307.71M | -105.07M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -89.12M | -89.61M | -87.61M | -83.19M | -79.89M |
| Other Financing Activities | -366.53M | -269.50M | -689.38M | -698.16M | -568.89M |
| Cash from Financing | -251.79M | -237.17M | -105.17M | -58.56M | -41.19M |
| Foreign Exchange rate Adjustments | 404.00K | -984.60K | -4.90M | -2.17M | 2.21M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -820.68M | -740.80M | -747.30M | -681.15M | -15.81M |